CORPORATE INFORMATION

Zinzino AB’s business operations began in the fall of 2007. The principal activity of the company is owing and developing companies within direct marketing and related business activities.

In 2009, Zinzino Nordic AB was partly acquired through a directed share issue to shareholders in Zinzino Nordic AB and partly through a subscription of shares, in the preferential rights issue, Zinzino Nordic AB carried out, in December 2009. This gave Zinzino AB control over 97% of the votes and 92% of the capital in Zinzino Nordic AB. As of December 31, 2014, ownership had
increased to 93% of the capital.

Since December 11, 2014, Zinzino AB has been listed on Nasdaq OMX First North.

Share performance has been very positive, especially over the past two years.

In 2011, the Group extended to include companies in Estonia and Lithuania. In 2012, companies were also launched in Latvia and Iceland. In 2013, a company was started in the USA, with its headquarters in Jupiter, Florida. Unlike the previous Group structure, the new subsidiaries are directly owned by Zinzino AB.
In 2014, companies were established in Poland and the Netherlands.

In 2014, Zinzino AB acquired the remaining shares in BioActive Foods AS and 85% of the shares in Faun Pharma AS.

A company was started in Canada, in 2015.

Figures in brief

  • For 2015, the Group’s total income amounted to SEK 443.8 (357.7) million, equivalent to a growth of 24% (41%).
  • Gross profit amounted to SEK 149.3 (102.4) million and the gross profit margin was 33.6% (28.6%).
  • EBITDA amounted to SEK 25.6 (21.4) million and the operating margin before depreciation was 5.8% (6.0%).
  • Depreciation and amortization amounted to SEK 7.1 (2.8) million, of which SEK 5.1 (0.5) million was attributable to
    amortization of goodwill.
  • Operating profit amounted to SEK 18.5 (18.6) million and the operating margin was 4.2% (5.2%).
  • Profit before tax amounted to SEK 17.6 (18.4) million. Earnings per share before tax amounted to SEK 0.6 (0.8)
    (before dilution).
  • Profit after tax amounted to 9.7 (32.7) million. Last year, deferred tax recoverables on tax loss carryforwards had a positive
    impact on profits of SEK 14.5 million.
  • The Board of Directors proposes a dividend of SEK 0.25 (0.25) per share, for the past year.
  • On closing day, cash and cash equivalents amounted to SEK 26.9 (42.8) million.